MedTrace Logo

Effect of DHEA on Patients With Poor Ovarian Responds

NCT02432248 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2023-07-20

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of DHEA for treatment of subfertile patients with poor ovarian reserve and post-treatment evaluation of IVF outcome.

Conditions

  • Subfertility

Interventions

DRUG

Dehydroepiandrosterone

75mg/day, PO for 90 days

OTHER

placebo(medical starch)

75mg/day, PO for 90 days

Sponsors & Collaborators

  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER

  • Renmin Hospital of Wuhan University

    collaborator OTHER

  • The Affiliated Hospital of Inner Mongolia Medical University

    lead OTHER

Principal Investigators

  • Yu Wang, PHD · The Affiliated Hospital of Inner Mongolia Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02432248 on ClinicalTrials.gov